|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61K 47/34 |
| (11) | Patento numeris | 3247394 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16740356.7 |
| Europos patento paraiškos padavimo data | 2016-01-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2016/000472 |
| Data | 2016-01-15 |
| (87) | Numeris | WO 2016/117883 |
| Data | 2016-07-28 |
| (30) | Numeris | Data | Šalis |
| 20150008677 | 2015-01-19 | KR |
| (72) |
CHOI, Yong Woon, KR
KIM, Yoo Hoon, KR
CHOI, Jungsub, KR
|
| (73) |
Green Cross Corporation,
107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do 16924,
KR
|
| (54) | PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODY |
| PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODY |